Orthofix Medical (OFIX) Fundamentals 2026 — Revenue Analysis | SniperIQ

1.11 on the NASDAQ. This SniperIQ fundamentals page covers Orthofix Medical's valuation, profitability (net margin -7.3%), revenue ($822M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Orthofix Medical's market cap?

Orthofix Medical (OFIX) has a market capitalization of approximately $449M, trading at

1.11 on the NASDAQ. Market cap moves with the live share price.

What is Orthofix Medical's P/E ratio?

Orthofix Medical's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Orthofix Medical?

Orthofix Medical runs a net profit margin of -7.3%, a gross margin of 69.0%, and an operating margin of -4.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Orthofix Medical generate?

Orthofix Medical reported revenue of $822M for fiscal year 2025, with net income of -$92M and earnings per share (EPS) of -2.28. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Orthofix Medical pay a dividend?

Orthofix Medical does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Orthofix Medical financially healthy?

Orthofix Medical carries a debt-to-equity ratio of 0.54x and a current ratio of 2.87x, with a market beta of 0.71. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Orthofix Medical a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Orthofix Medical (OFIX) the key facts are: market cap $449M, revenue $822M, 52-week range 8.85-16.99. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.